Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction View Post
EitC Teams Up With AstraZeneca To Launch England’s First Community-Based Heart And Lung Screening Hub View Post
Pumping Marvellous Foundation statement and response to the Observer article dated 23rd July 2023 View Post